Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial
Resource Type
Article
Authors
Rosenfeld, Margaret ; Starner, Timothy ; Retsch-Bogart, George ; Chmiel, James ; Orenstein, David ; Milla, Carlos ; Rubenstein, Ronald ; Walker, Seth ; Cornell, Alexandra ; Asfour, Fadi ; Black, Philip ; Colombo, John ; Froh, Deborah ; McColley, Susanna ; Ruiz, Fadel ; Quintero, Diana ; Casey, Alicia ; Mueller, Gary ; Flume, Patrick ; Livingston, Floyd ; Rock, Michael ; O'Sullivan, Brian ; Schmidt, Howard ; Lahiri, Thomas ; McNamara, John ; Chidekel, Aaron ; Sass, Laura ; Keens, Thomas ; Schaeffer, David ; Solomon, Melinda ; Chilvers, Mark ; Lands, Larry ; Junge, Sibylle ; Griese, Matthias ; Staab, Doris ; Pressler, Tacjana ; van Koningsburggen-Rietschel, Silke ; Naehrlich, Lutz ; Reid, Alastair ; Balfour-Lynn, Ian ; Urquhart, Don ; Lee, Timothy ; Munck, Anne ; Gaudelus, Isabelle Sermet ; De Boeck, Christiane ; Reix, Philippe ; Malfroot, Anne ; Bui, Stéphanie ; Selvadurai, Hiranjan ; Robinson, Philip ; Wainwright, Claire ; Clements, Barry ; Hilton, Jodi ; Hjelte, Lena ; Ratjen, Felix ; Hug, Christopher ; Marigowda, Gautham ; Tian, Simon ; Huang, Xiaohong ; Stanojevic, Sanja ; Milla, Carlos E ; Robinson, Paul D ; Waltz, David ; Davies, Jane C
Source
In The Lancet Respiratory Medicine July 2017 5(7):557-567
Subject
Primary Research Articles
Language
ISSN
2213-2600